Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer

Increased levels of physical activity are associated with a reduction of breast cancer mortality, especially in postmenopausal women with positive hormone receptor status. So far, previous observational case-control and cohort studies have focused on associations between overall leisure time physica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zimmer, Philipp (VerfasserIn) , Esser, Tobias (VerfasserIn) , Lueftner, Diana (VerfasserIn) , Schütz, Florian (VerfasserIn) , Baumann, Freerk T. (VerfasserIn) , Rody, Achim (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Hartkopf, Andreas D. (VerfasserIn) , Decker, Thomas (VerfasserIn) , Uleer, Christoph (VerfasserIn) , Stoetzer, Oliver J. (VerfasserIn) , Foerster, Frank (VerfasserIn) , Schmidt, Marcus (VerfasserIn) , Mundhenke, Christoph (VerfasserIn) , Steindorf, Karen (VerfasserIn) , Tesch, Hans (VerfasserIn) , Jackisch, Christian (VerfasserIn) , Fischer, Thomas (VerfasserIn) , Hanson, Sven (VerfasserIn) , Kreuzeder, Julia (VerfasserIn) , Guderian, Gernot (VerfasserIn) , Fasching, Peter A. (VerfasserIn) , Bloch, Wilhelm (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 08 October 2024
In: BMC medicine
Year: 2024, Jahrgang: 22, Heft: 1, Pages: 1-10
ISSN:1741-7015
DOI:10.1186/s12916-024-03671-x
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12916-024-03671-x
Verlag, kostenfrei, Volltext: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03671-x
Volltext
Verfasserangaben:Philipp Zimmer, Tobias Esser, Diana Lueftner, Florian Schuetz, Freerk T. Baumann, Achim Rody, Andreas Schneeweiss, Andreas D. Hartkopf, Thomas Decker, Christoph Uleer, Oliver J. Stoetzer, Frank Foerster, Marcus Schmidt, Christoph Mundhenke, Karen Steindorf, Hans Tesch, Christian Jackisch, Thomas Fischer, Sven Hanson, Julia Kreuzeder, Gernot Guderian, Peter A. Fasching and Wilhelm Bloch

MARC

LEADER 00000caa a2200000 c 4500
001 1923727745
003 DE-627
005 20250717011744.0
007 cr uuu---uuuuu
008 250428s2024 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12916-024-03671-x  |2 doi 
035 |a (DE-627)1923727745 
035 |a (DE-599)KXP1923727745 
035 |a (OCoLC)1528044958 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zimmer, Philipp  |d 1983-  |e VerfasserIn  |0 (DE-588)174009445  |0 (DE-627)698907728  |0 (DE-576)134845846  |4 aut 
245 1 0 |a Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer  |c Philipp Zimmer, Tobias Esser, Diana Lueftner, Florian Schuetz, Freerk T. Baumann, Achim Rody, Andreas Schneeweiss, Andreas D. Hartkopf, Thomas Decker, Christoph Uleer, Oliver J. Stoetzer, Frank Foerster, Marcus Schmidt, Christoph Mundhenke, Karen Steindorf, Hans Tesch, Christian Jackisch, Thomas Fischer, Sven Hanson, Julia Kreuzeder, Gernot Guderian, Peter A. Fasching and Wilhelm Bloch 
264 1 |c 08 October 2024 
300 |b Diagramme 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel erscheint das + hochgestellt 
500 |a Gesehen am 28.04.2025 
520 |a Increased levels of physical activity are associated with a reduction of breast cancer mortality, especially in postmenopausal women with positive hormone receptor status. So far, previous observational case-control and cohort studies have focused on associations between overall leisure time physical activity and survival of women with breast cancer in general. In this multicenter prospective cohort study, conducted in Germany between 30th August 2012 to 29th December 2017, we investigated general physical activity in a homogenous sample of n = 1440 postmenopausal women with advanced (inoperable locally advanced or metastatic), hormone receptor-positive breast cancer receiving the same therapy (everolimus and exemestane). Self-reported physical activity was assessed using the Godin Leisure Time Exercise Questionnaire (GLTEQ) before and every 3 months during treatment. Participants were then classified into “active” and “insufficiently active” to screen their activity behavior the week prior to medical treatment. In addition, changes in physical activity patterns were assessed. Adjusted Cox regression analyses were performed for the activity categories to determine hazard ratios (HR). Besides progression-free survival (PFS), adverse events (AEs), QoL, and fatigue were assessed every 3 months until study termination. Compared to “insufficiently active” patients, “active” individuals indicated a significantly longer PFS (HR: 0.84 [0.74; 0.984], p = .0295). No significant differences were observed for changes of physical activity behavior. Patients who reported to be “active” at baseline revealed significantly fewer AEs compared to “insufficiently” active patients. In detail, both severe and non-severe AEs occurred less frequently in the “active” patients group. In line with that, QoL and fatigue were better in physical “active” patients compared to their insufficient active counterparts at the last post-baseline assessment. Participants who remained or become active indicated less AEs, a higher QoL, and reduced fatigue levels. Physical activity behavior prior to medical treatment might have prognostic value in patients with advanced breast cancer in terms of extending the PFS. Moreover, physical activity before and during treatment may reduce treatment-related side effects and improve patients’ QoL and fatigue. EUPAS9462. Registered 30th October 2012 “retrospectively registered.” 
700 1 |a Esser, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Lueftner, Diana  |e VerfasserIn  |4 aut 
700 1 |a Schütz, Florian  |d 1972-  |e VerfasserIn  |0 (DE-588)12303387X  |0 (DE-627)082307229  |0 (DE-576)293528810  |4 aut 
700 1 |a Baumann, Freerk T.  |e VerfasserIn  |4 aut 
700 1 |a Rody, Achim  |e VerfasserIn  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Hartkopf, Andreas D.  |e VerfasserIn  |4 aut 
700 1 |a Decker, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Uleer, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Stoetzer, Oliver J.  |e VerfasserIn  |4 aut 
700 1 |a Foerster, Frank  |e VerfasserIn  |4 aut 
700 1 |a Schmidt, Marcus  |e VerfasserIn  |4 aut 
700 1 |a Mundhenke, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Steindorf, Karen  |e VerfasserIn  |0 (DE-588)104608075X  |0 (DE-627)775694665  |0 (DE-576)399366024  |4 aut 
700 1 |a Tesch, Hans  |e VerfasserIn  |4 aut 
700 1 |a Jackisch, Christian  |e VerfasserIn  |4 aut 
700 1 |a Fischer, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Hanson, Sven  |e VerfasserIn  |4 aut 
700 1 |a Kreuzeder, Julia  |e VerfasserIn  |4 aut 
700 1 |a Guderian, Gernot  |e VerfasserIn  |4 aut 
700 1 |a Fasching, Peter A.  |e VerfasserIn  |4 aut 
700 1 |a Bloch, Wilhelm  |d 1959-  |e VerfasserIn  |0 (DE-588)114751765  |0 (DE-627)526863846  |0 (DE-576)289807433  |4 aut 
773 0 8 |i Enthalten in  |t BMC medicine  |d London : BioMed Central, 2003  |g 22(2024), 1, Artikel-ID 442, Seite 1-10  |h Online-Ressource  |w (DE-627)377271225  |w (DE-600)2131669-7  |w (DE-576)121906655  |x 1741-7015  |7 nnas  |a Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer 
773 1 8 |g volume:22  |g year:2024  |g number:1  |g elocationid:442  |g pages:1-10  |g extent:10  |a Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer 
856 4 0 |u https://doi.org/10.1186/s12916-024-03671-x  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-024-03671-x  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250428 
993 |a Article 
994 |a 2025 
998 |g 104608075X  |a Steindorf, Karen  |m 104608075X:Steindorf, Karen  |d 50000  |e 50000PS104608075X  |k 0/50000/  |p 15 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |d 50000  |e 910000PS109972554  |e 910400PS109972554  |e 50000PS109972554  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 7 
998 |g 12303387X  |a Schütz, Florian  |m 12303387X:Schütz, Florian  |d 50000  |e 50000PS12303387X  |k 0/50000/  |p 4 
999 |a KXP-PPN1923727745  |e 4710823391 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"08 October 2024","dateIssuedKey":"2024"}],"physDesc":[{"noteIll":"Diagramme","extent":"10 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Philipp Zimmer, Tobias Esser, Diana Lueftner, Florian Schuetz, Freerk T. Baumann, Achim Rody, Andreas Schneeweiss, Andreas D. Hartkopf, Thomas Decker, Christoph Uleer, Oliver J. Stoetzer, Frank Foerster, Marcus Schmidt, Christoph Mundhenke, Karen Steindorf, Hans Tesch, Christian Jackisch, Thomas Fischer, Sven Hanson, Julia Kreuzeder, Gernot Guderian, Peter A. Fasching and Wilhelm Bloch"]},"id":{"doi":["10.1186/s12916-024-03671-x"],"eki":["1923727745"]},"person":[{"display":"Zimmer, Philipp","family":"Zimmer","role":"aut","given":"Philipp"},{"display":"Esser, Tobias","family":"Esser","role":"aut","given":"Tobias"},{"given":"Diana","role":"aut","family":"Lueftner","display":"Lueftner, Diana"},{"given":"Florian","role":"aut","family":"Schütz","display":"Schütz, Florian"},{"display":"Baumann, Freerk T.","family":"Baumann","role":"aut","given":"Freerk T."},{"family":"Rody","display":"Rody, Achim","given":"Achim","role":"aut"},{"display":"Schneeweiss, Andreas","family":"Schneeweiss","role":"aut","given":"Andreas"},{"display":"Hartkopf, Andreas D.","family":"Hartkopf","role":"aut","given":"Andreas D."},{"family":"Decker","display":"Decker, Thomas","given":"Thomas","role":"aut"},{"role":"aut","given":"Christoph","display":"Uleer, Christoph","family":"Uleer"},{"display":"Stoetzer, Oliver J.","family":"Stoetzer","role":"aut","given":"Oliver J."},{"family":"Foerster","display":"Foerster, Frank","given":"Frank","role":"aut"},{"role":"aut","given":"Marcus","display":"Schmidt, Marcus","family":"Schmidt"},{"role":"aut","given":"Christoph","display":"Mundhenke, Christoph","family":"Mundhenke"},{"role":"aut","given":"Karen","display":"Steindorf, Karen","family":"Steindorf"},{"role":"aut","given":"Hans","display":"Tesch, Hans","family":"Tesch"},{"family":"Jackisch","display":"Jackisch, Christian","given":"Christian","role":"aut"},{"role":"aut","given":"Thomas","display":"Fischer, Thomas","family":"Fischer"},{"role":"aut","given":"Sven","display":"Hanson, Sven","family":"Hanson"},{"given":"Julia","role":"aut","family":"Kreuzeder","display":"Kreuzeder, Julia"},{"family":"Guderian","display":"Guderian, Gernot","given":"Gernot","role":"aut"},{"role":"aut","given":"Peter A.","display":"Fasching, Peter A.","family":"Fasching"},{"family":"Bloch","display":"Bloch, Wilhelm","given":"Wilhelm","role":"aut"}],"recId":"1923727745","relHost":[{"note":["Gesehen am 29.10.13"],"id":{"zdb":["2131669-7"],"eki":["377271225"],"issn":["1741-7015"]},"title":[{"title_sort":"BMC medicine","title":"BMC medicine"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"377271225","pubHistory":["1.2003 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"extent":"10","year":"2024","pages":"1-10","text":"22(2024), 1, Artikel-ID 442, Seite 1-10","issue":"1","volume":"22"},"origin":[{"dateIssuedKey":"2003","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2003-","publisherPlace":"London ; Berlin ; Heidelberg [u.a.]"}],"disp":"Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancerBMC medicine"}],"note":["Im Titel erscheint das + hochgestellt","Gesehen am 28.04.2025"],"title":[{"title_sort":"Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer","title":"Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer"}],"language":["eng"]} 
SRT |a ZIMMERPHILPHYSICALAC0820